USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18009
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSprincean, Mariana
dc.contributor.authorHadjiu, Svetlana
dc.contributor.authorLupușor, Nadejda
dc.contributor.authorGriu, Corina
dc.contributor.authorCuznet, Ludmila
dc.contributor.authorRacovita, Stela
dc.contributor.authorFeghiu, Ludmila
dc.contributor.authorCalcii, Cornelia
dc.contributor.authorRevenco, Ninel
dc.contributor.authorGroppa, Stanislav
dc.date.accessioned2021-09-27T14:32:41Z
dc.date.available2021-09-27T14:32:41Z
dc.date.issued2021
dc.identifier.citationSPRINCEAN, Mariana, HADJIU, Svetlana, LUPUSOR, Nadejda, GRIU, Corina, CUZNET, Ludmila, et al. Immunoenzymatic changes in ischemic stroke in children. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 25. ISSN 2537-6381.
dc.identifier.issn2537-6373
dc.identifier.issn2537-6381
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18009
dc.description.abstractBackground: Ischemic stroke (IS) in children is a major neurological emergency, being a primary cause of morbidity and mortality. The incidence of IS is 2 – 13:100000 children or 1:4000 in neonatal period. The purpose of the study was evaluation of the expressivity of immune parameters in children with IS to improve understanding of pathogenesis, early diagnosis and predictive factors of the disease. Material and methods: In 2017 − 2019 in the Republic of Moldova a prospective study was carried out on a sample of 53 children with IS (study sample, SS), investigated by ELISA in the acute phase of the process determining the serum levels of endogline CD105 (ENG), S100B protein, vascular endothelial growth factor (VEGF), ciliary neurotrophic factor (CNTF), antiphospholipid antibodies (APA), and interleukin 6 (IL-6). These markers were also appreciated in 53 ”practically healthy” children (control sample, CS). Six months after IS, serum levels of VEGF and S100B were re-assessed. Results: Medium values of markers in acute phase were as follows: (1) ENG – 2.06 ± 0.012 ng/ml (F=84.812, p<0.001); (2) S-100B – 0.524 ± 0.0850 ng/ml (F=9.330, p<0.01); (3) VEGF – 613.41 ± 39.299 pg/ml (F=60.701, p<0.001); (4) CNTF – 7.84 ± 0.322 pg/ml (F=32.550, p<0.001); (5) APA –1.37 ± 0.046 U/ml (F=60.701, p<0.001); (6) IL-6 – 22.02 ± 2.143 pg/ml (F=43.810, p<0.001), which were significantly different from the levels in CS. Conclusions: During the acute period of stroke in children, an increased serum level of the protein S100B, VEGF, CNTF, APA and IL-6 is observed, while CD 105 has low levels. These changes can have predictive role to improve prognosis of neurological outcome.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectbiomarkersen_US
dc.subjectstrokeen_US
dc.subjectchildrenen_US
dc.titleImmunoenzymatic changes in ischemic stroke in childrenen_US
dc.typeOtheren_US
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021

Files in This Item:
File Description SizeFormat 
Immunoenzymatic_changes_in_ischemic_stroke_in_children.pdf75.29 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback